Finafloxacin
CAS 209342-40-5Small Molecule
Overview
Finafloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1908370).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Finafloxacin expires 21 Nov 2033. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
- Canonical SMILES
- C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4C[C@H]5[C@H](C4)OCCN5)F)C(=O)O
- InChIKey
- FYMHQCNFKNMJAV-HOTGVXAUSA-N
Verified Supplier Partner
Do you supply Finafloxacin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.